Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced participation in the following industry and scientific conferences in July:
- July 5-6: 3rd FORUM Science & Health: Medicine of the Future. Members of Immunic’s management and communications teams will attend this conference in Fürstenfeldbruck near Munich, Germany.
- July 6-9: 16th World Immune Regulation Meeting. Evelyn Peelen, Ph.D., Senior Manager Translational Pharmacology at Immunic, will present preclinical data on IMU-935, the company’s potentially best-in-class oral IL-17 inhibitor, in poster and workshop presentations, at this conference in Davos, Switzerland. The poster presentation will be accessible on the “Events and Presentations” section of Immunic’s website at: https://ir.imux.com/events-and-presentations.
- Title: IMU-935, an Orally Available RORgammaT Inverse Agonist in Phase 1 Clinical Trial for Psoriasis, Inhibits Th17-Dependent Autoimmunity without Inducing Thymocyte Aberrations
- Poster Session: Workshop Poster W12-Autoimmunity
- Date/Time: Friday, July 8, 2022, 7:30 pm CEST
- Room: Main Corridor
- Title: IMU-935, an Orally Available RORgammaT Inverse Agonist in Phase 1 Clinical Trial for Psoriasis, Inhibits Th17-Dependent Autoimmunity without Inducing Thymocyte Aberrations
-
- Workshop Title: W12-Autoimmunity
-
- Workshop Date/Time: Saturday, July 9, 2022, 2:00 pm – 3:00 pm CEST
- Presentation Time: 2:10 – 2:20pm CEST
- Room: Forum
-
- Workshop Title: W12-Autoimmunity
- July 26-28: B & T Cell-Mediated Autoimmune Disease Drug Development Summit. Dr. Peelen will discuss preclinical insights on the company’s oral IL-17 inhibitor, IMU-935, in a presentation entitled, “IMU-935, a potent RORyt inverse agonist, effectively inhibits T helper 17 cells but maintains normal thymocyte development,” on Thursday, July 28, 2022 at 11:00 am EDT, in Boston. The presentation will be accessible on the “Events and Presentations” section of Immunic’s website at: https://ir.imux.com/events-and-presentations.
PRNewswire
previous
Global Location Analytics Market to Reach $24.9 Billion by 2026
next